Bill Ackman made nearly nearly $170 million in one day in a Valeant two-day rally. His comment on Valeant Pharmaceutical showed his capability as a remarkable hedge fund manager.
In the continuing saga on Valeant, CFO Howard Schiller has been asked to resign. The company will also find the replacement of CEO Michael Pearson, and putting Bill Ackman in its board.
Following Valeant Pharmaceuticals' meltdown, S&P rating service puts Pershing Square Holdings Ltd on review. However, S&P acknowledged swift decision by the firm to strengthen its liquidity after a massive loss.
A huge slump in Valeant Pharmaceutical stocks on Tuesday made Pershing Capital to lose more than $1 billion in one day. Meanwhile Bill Ackman planned to take more active role in the drugmaker.
The Canadian drugmaker on Wednesday announced to add three new directors to its board. Representative from Pershing Square Capital Management was added as one of the directors.
Pershing Square Holdings, a fund managed by activist investor Bill Ackman, raised $3.07 billion ahead of a stock market listing in Amsterdam, the company said on Wednesday.
T. Rowe Price, the second largest shareholder in Allergan Inc (AGN.N), said on Friday that it wants the company to hold off on making major moves before a Dec. 18 special shareholder meeting, and criticized the board on its corporate governance.
Pershing Square Holdings, a fund managed by activist investor Bill Ackman, hopes to raise $2 billion from a listing on the Euronext Amsterdam stock exchange, the company said in a statement on Monday.
Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.
With activist investors amassing wealth because of their campaigns, investment banks are now providing clients investment advice that would enable companies to anticipate and foil the efforts of activist investors, Bloomberg reported.
Despite getting clearance from accounting firm PricewaterhouseCoopers LLP regarding its fiscal statements for the last three years, activist investor Bill Ackman appeared to be not convinced that Herbalife Ltd is not operating a pyramid scheme.
Bloomberg said in its report that nutrition company Herbalife Ltd attempted to destroy activist investor Bill Ackman's credibility after the latter claimed that the former is running a pyramid scheme.
Investors showed support in nutrition company Herbalife International on the stock exchange on Friday despite another attack from activist investor Bill Ackman of hedge fund Pershing Square Capital Management.
The following bids, mergers, acquisitions and disposals were reported on Monday including Forbes, Axel Springer, MidCap Financial LLC, Goldman Sachs and others.
Although taking different approaches, investors Bill Ackman and Bruce Berkowitz were attempting to salvage securities acquired before the US housing crisis with a combined value of more than USD100 billion, said a Bloomberg report.